celastrol has been researched along with Cancer of Esophagus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pan, J; Tan, F; Tu, Y; Zhou, J | 1 |
Huang, P; Sun, LY; Zhang, YQ | 1 |
Wu, CL; Xu, J | 1 |
3 other study(ies) available for celastrol and Cancer of Esophagus
Article | Year |
---|---|
Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Male; Mice; Mice, Nude; Molecular Conformation; Neoplasm Invasiveness; NF-kappa B; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2018 |
A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Biological Products; Cell Cycle Checkpoints; Cell Line, Tumor; Esophageal Neoplasms; Humans; Mice; Mice, Inbred BALB C; Pentacyclic Triterpenes; Triterpenes | 2019 |
[Anti-metastasis of celastrol on esophageal cancer cells and its mechanism].
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Esophageal Neoplasms; Humans; Pentacyclic Triterpenes; Real-Time Polymerase Chain Reaction; Triterpenes; Wnt Signaling Pathway | 2015 |